When Hepatitis B Virus Meets Interferons
Chronic hepatitis B virus (HBV) infection imposes a severe burden on global public health. Currently, there are no curative therapies for millions of chronic HBV-infected patients (Lok et al., 2017). Interferon (IFN; including pegylated IFN) is an approved anti-HBV drug that not only exerts direct a...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2018-07-01
|
| Serie: | Frontiers in Microbiology |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/article/10.3389/fmicb.2018.01611/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|